Reaction
Meniscus Lesion reporting signals
As of the last recalculation, Meniscus Lesion appears in 1,392 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 25.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alendronate Sodium | 152 | 25.2 | 25.2 |
| Raloxifene Hydrochloride | 17 | 17.6 | 17.6 |
| Ezetimibe And Simvastatin | 12 | 11.9 | 11.9 |
| Amlodipine Besylate And Benazepril Hydrochloride | 7 | 11.4 | 11.4 |
| Estrogens, Conjugated | 40 | 10.3 | 10.3 |
| Conjugated Estrogens | 39 | 10.3 | 10.3 |
| Anastrozole | 24 | 9.9 | 9.9 |
| Interferon Beta-1A | 101 | 8.4 | 8.4 |
| Pseudoephedrine Hydrochloride | 4 | 5.8 | 5.8 |
| Exenatide | 19 | 5.5 | 5.5 |
| Pseudoephedrine Hcl | 4 | 5.4 | 5.4 |
| Paricalcitol | 5 | 5.3 | 5.3 |
| Sevelamer Carbonate | 4 | 5.2 | 5.2 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 8 | 5.1 | 5.1 |
| Natalizumab | 58 | 4.9 | 4.9 |
| Hydrocodone Bitartrate | 14 | 4.9 | 4.9 |
| Cinacalcet Hydrochloride | 6 | 1.9 | 1.9 |